Early C‐reactive Protein Kinetics Predict Response to Immune Checkpoint Blockade in Unresectable Hepatocellular Carcinoma

PURPOSE: In recent years, a new therapeutic approach, known as immune checkpoint blockade (ICB), has been proposed as approach to improve outcomes in patients with intermediate stage (Barcelona Clinic Liver Cancer, BCLC B) or advanced stage (BCLC C) hepatocellular carcinoma (HCC). Unfortunately, onl...

Descripción completa

Detalles Bibliográficos
Autores principales: Qin, Qiuying, Kou, Xiaoxuan, Zheng, Yuanyuan, Zhou, Fei, Zhang, Xiaoyong, Liu, Hongyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637213/
https://www.ncbi.nlm.nih.gov/pubmed/37954495
http://dx.doi.org/10.2147/JHC.S432054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637213/
https://www.ncbi.nlm.nih.gov/pubmed/37954495
http://dx.doi.org/10.2147/JHC.S432054

Ejemplares similares